Virpax Pharmaceuticals Inc (VRPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,022 | -5,137 | -12,056 | -7,938 | -4,723 |
| Accounts payable and accrued liabilities | 396 | 99 | -687 | -1,453 | -9 |
| Other Working Capital | -215 | -1,119 | -3,399 | -2,453 | -911 |
| Other Operating Activity | 60 | 112 | 1,599 | 2,225 | 765 |
| Operating Cash Flow | $-10,781 | $-6,045 | $-14,543 | $-9,620 | $-4,878 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 100 | 100 | 100 |
| Debt Repayment | N/A | N/A | -1,604 | -1,604 | -594 |
| Common Stock Issued | N/A | N/A | 58,020 | 18,000 | 18,000 |
| Other Financing Activity | 0 | 0 | -5,186 | 34,783 | -2,217 |
| Financing Cash Flow | $N/A | $N/A | $51,330 | $51,279 | $15,290 |
| Beginning Cash Position | 36,842 | 36,842 | 55 | 55 | 55 |
| End Cash Position | 26,061 | 30,797 | 36,842 | 41,713 | 10,467 |
| Net Cash Flow | $-10,781 | $-6,045 | $36,787 | $41,659 | $10,412 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,781 | -6,045 | -14,543 | -9,620 | -4,878 |
| Free Cash Flow | -10,781 | -6,045 | -14,543 | -9,620 | -4,878 |